206 related articles for article (PubMed ID: 36702998)
21. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous expression of apolipoprotein B mRNA editing enzyme and scavenger receptor BI mediated by a therapeutic gene expression system.
Zhong S; Liu C; Haviland D; Doris PA; Teng BB
Atherosclerosis; 2006 Feb; 184(2):264-75. PubMed ID: 15979078
[TBL] [Abstract][Full Text] [Related]
23. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
[TBL] [Abstract][Full Text] [Related]
24. Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase.
Anant S; Yu H; Davidson NO
Biol Chem; 1998; 379(8-9):1075-81. PubMed ID: 9792440
[TBL] [Abstract][Full Text] [Related]
25. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.
Hirano K; Young SG; Farese RV; Ng J; Sande E; Warburton C; Powell-Braxton LM; Davidson NO
J Biol Chem; 1996 Apr; 271(17):9887-90. PubMed ID: 8626621
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human apobec-1 gene: expression in gastrointestinal tissues determined by alternative splicing with production of a novel truncated peptide.
Hirano K; Min J; Funahashi T; Baunoch DA; Davidson NO
J Lipid Res; 1997 May; 38(5):847-59. PubMed ID: 9186903
[TBL] [Abstract][Full Text] [Related]
27. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
[TBL] [Abstract][Full Text] [Related]
29. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
30. Hypermutation induced by APOBEC-1 overexpression can be eliminated.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Csako G; Patterson AP
RNA; 2010 May; 16(5):1040-52. PubMed ID: 20348446
[TBL] [Abstract][Full Text] [Related]
31. apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53.
Ashur-Fabian O; Har-Zahav A; Shaish A; Wiener Amram H; Margalit O; Weizer-Stern O; Dominissini D; Harats D; Amariglio N; Rechavi G
Cell Cycle; 2010 Sep; 9(18):3761-70. PubMed ID: 20890106
[TBL] [Abstract][Full Text] [Related]
32. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
33. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
Krause K; Marcu KB; Greeve J
Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
[TBL] [Abstract][Full Text] [Related]
34. Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through APOBEC-1 affinity chromatography.
Yang Y; Yang Y; Kovalski K; Smith HC
J Biol Chem; 1997 Oct; 272(44):27700-6. PubMed ID: 9346911
[TBL] [Abstract][Full Text] [Related]
35. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
Chester A; Scott J; Anant S; Navaratnam N
Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
[TBL] [Abstract][Full Text] [Related]
36. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
Severi F; Chicca A; Conticello SG
Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
[TBL] [Abstract][Full Text] [Related]
37. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA.
Yang Y; Sowden MP; Yang Y; Smith HC
Exp Cell Res; 2001 Jul; 267(2):153-64. PubMed ID: 11426934
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
Mehta A; Kinter MT; Sherman NE; Driscoll DM
Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
[TBL] [Abstract][Full Text] [Related]
39. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
Anant S; Davidson NO
Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
[TBL] [Abstract][Full Text] [Related]
40. Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes.
von Wronski MA; Hirano KI; Cagen LM; Wilcox HG; Raghow R; Thorngate FE; Heimberg M; Davidson NO; Elam MB
Metabolism; 1998 Jul; 47(7):869-73. PubMed ID: 9667237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
